M
Meta Health Ltd
SGX:5DX
Meta Health Ltd
SGX:5DX
Price:
0.005
SGD
Market Closed
Market Cap:
S$6.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Meta Health Ltd
SGX:5DX
|
SG |
|
S
|
Sbc Corporation Bhd
KLSE:SBCCORP
|
MY |
|
Weilong Grape Wine Co Ltd
SSE:603779
|
CN |
|
O
|
Oil Refineries Ltd
TASE:ORL
|
IL |
|
I
|
Infinity Stone Ventures Corp
CNSX:GEMS
|
CA |
|
I
|
IDI Insurance Company Ltd
TASE:IDIN
|
IL |
|
Ares International Corp
TWSE:2471
|
TW |
|
Pinstripes Holdings Inc
NYSE:PNST
|
US |
Balance Sheet
Balance Sheet Decomposition
Meta Health Ltd
Meta Health Ltd
Balance Sheet Decomposition is not available for
Meta Health Ltd
Meta Health Ltd
Balance Sheet
Meta Health Ltd
Meta Health Ltd
Currency: SGD
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
6
|
8
|
12
|
5
|
8
|
7
|
8
|
8
|
8
|
5
|
11
|
11
|
11
|
11
|
9
|
5
|
2
|
2
|
4
|
10
|
3
|
3
|
0
|
0
|
|
| Cash |
6
|
8
|
12
|
5
|
8
|
7
|
8
|
8
|
8
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
11
|
11
|
11
|
9
|
5
|
2
|
2
|
4
|
10
|
3
|
3
|
0
|
0
|
|
| Total Receivables |
19
|
18
|
23
|
25
|
24
|
27
|
22
|
18
|
18
|
19
|
18
|
22
|
25
|
21
|
20
|
17
|
13
|
11
|
11
|
13
|
8
|
1
|
1
|
1
|
|
| Accounts Receivables |
18
|
16
|
21
|
24
|
23
|
27
|
20
|
18
|
18
|
18
|
18
|
22
|
25
|
21
|
20
|
17
|
13
|
11
|
11
|
13
|
8
|
1
|
1
|
1
|
|
| Other Receivables |
1
|
2
|
2
|
1
|
1
|
0
|
2
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
6
|
6
|
9
|
16
|
13
|
11
|
13
|
10
|
10
|
9
|
6
|
8
|
8
|
7
|
4
|
5
|
4
|
3
|
4
|
4
|
3
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
1
|
1
|
3
|
10
|
4
|
7
|
4
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
14
|
1
|
0
|
3
|
0
|
0
|
|
| Total Current Assets |
31
|
31
|
44
|
47
|
46
|
47
|
46
|
47
|
40
|
40
|
40
|
41
|
44
|
40
|
33
|
29
|
21
|
19
|
32
|
28
|
15
|
8
|
1
|
1
|
|
| PP&E Net |
19
|
20
|
24
|
38
|
35
|
35
|
34
|
26
|
24
|
21
|
18
|
20
|
18
|
16
|
14
|
21
|
20
|
25
|
11
|
10
|
7
|
0
|
0
|
0
|
|
| PP&E Gross |
19
|
20
|
24
|
38
|
35
|
35
|
34
|
26
|
24
|
21
|
18
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
10
|
12
|
14
|
43
|
38
|
39
|
35
|
23
|
26
|
29
|
31
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
51
N/A
|
52
+2%
|
68
+32%
|
85
+25%
|
81
-5%
|
83
+2%
|
80
-3%
|
73
-9%
|
65
-12%
|
60
-7%
|
58
-4%
|
62
+6%
|
62
0%
|
58
-6%
|
48
-17%
|
50
+5%
|
42
-17%
|
44
+5%
|
43
-1%
|
40
-7%
|
22
-44%
|
8
-64%
|
2
-80%
|
2
+11%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
22
|
15
|
22
|
30
|
27
|
27
|
22
|
19
|
13
|
14
|
13
|
20
|
21
|
19
|
16
|
19
|
14
|
12
|
16
|
14
|
9
|
2
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
6
|
4
|
9
|
13
|
16
|
17
|
19
|
10
|
13
|
11
|
10
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
2
|
3
|
5
|
4
|
3
|
3
|
3
|
2
|
2
|
2
|
11
|
13
|
10
|
8
|
4
|
6
|
6
|
3
|
4
|
5
|
2
|
2
|
2
|
|
| Other Current Liabilities |
1
|
1
|
3
|
1
|
2
|
1
|
1
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
0
|
0
|
3
|
0
|
0
|
|
| Total Current Liabilities |
31
|
22
|
37
|
47
|
49
|
49
|
44
|
38
|
33
|
32
|
29
|
31
|
34
|
30
|
23
|
26
|
23
|
22
|
22
|
19
|
14
|
7
|
3
|
3
|
|
| Long-Term Debt |
7
|
3
|
5
|
13
|
10
|
8
|
6
|
7
|
5
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
5
|
5
|
4
|
2
|
0
|
0
|
|
| Deferred Income Tax |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
1
|
1
|
3
|
2
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
39
N/A
|
27
-30%
|
43
+59%
|
63
+46%
|
62
-2%
|
59
-4%
|
52
-12%
|
46
-11%
|
38
-18%
|
35
-9%
|
30
-13%
|
33
+8%
|
35
+7%
|
30
-12%
|
24
-21%
|
29
+20%
|
26
-9%
|
27
+1%
|
28
+3%
|
24
-13%
|
17
-29%
|
8
-51%
|
3
-63%
|
3
-1%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
2
|
11
|
11
|
11
|
18
|
18
|
18
|
18
|
20
|
20
|
21
|
21
|
22
|
22
|
22
|
22
|
22
|
22
|
22
|
29
|
29
|
32
|
32
|
33
|
|
| Retained Earnings |
9
|
13
|
13
|
11
|
2
|
6
|
9
|
9
|
8
|
5
|
8
|
8
|
5
|
6
|
2
|
1
|
6
|
5
|
6
|
13
|
24
|
32
|
33
|
35
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
11
N/A
|
24
+112%
|
25
+2%
|
22
-11%
|
19
-12%
|
23
+19%
|
28
+20%
|
27
-4%
|
26
-1%
|
26
-4%
|
28
+9%
|
29
+4%
|
27
-8%
|
27
+2%
|
24
-14%
|
21
-11%
|
15
-28%
|
17
+10%
|
15
-9%
|
16
+3%
|
5
-68%
|
0
N/A
|
2
-215%
|
1
+14%
|
|
| Total Liabilities & Equity |
51
N/A
|
52
+2%
|
68
+32%
|
85
+25%
|
81
-5%
|
83
+2%
|
80
-3%
|
73
-9%
|
65
-12%
|
60
-7%
|
58
-4%
|
62
+6%
|
62
0%
|
58
-6%
|
48
-17%
|
50
+5%
|
42
-17%
|
44
+5%
|
43
-1%
|
40
-7%
|
22
-44%
|
8
-64%
|
2
-80%
|
2
+11%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
160
|
200
|
200
|
200
|
254
|
254
|
254
|
254
|
305
|
305
|
360
|
365
|
373
|
374
|
374
|
374
|
374
|
374
|
459
|
643
|
685
|
1 061
|
1 399
|
1 320
|
|
| Preferred Shares Outstanding |
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
